← All stocks

Edesa Biotech, Inc.

EDSA Net buying
CIK 0001540159 #4753 in the set updated 21 Sep 2026
Bought (12 mo)
$233.05K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$233.05K
+$233.05K against sales at will

By person

9 insiders · 9 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Nijhawan Pardeep
Chief Executive Officer
$229.91K (8)
+$229.91K
1,822,230
$12.02M
+83.8%
Brooks Michael J
President
$3.14K (1)
+$3.14K
291,479
$1.92M
+1,550%
Weiler Peter J.
Chief Financial Officer
129,609
$855.28K
Marshall Patrick
Director
71,666
$472.92K
Sistilli Carlo
Director
49,417
$326.10K
MacDonald Sean Arthur
Director
41,054
$270.91K
+1,900%
Chypyha Joan
Director
30,029
$198.16K
+103,448%
Olson Charles V
Director
30,000
$197.97K
Liu Da David
Director
24,501
$161.68K

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 3,467,658 to 9,641,031 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Nijhawan Pardeep
10 Mar 2026
Chief Executive Officer
Buy
1,000
$6.60
$6.60K
Nijhawan Pardeep
5 Mar 2026
Chief Executive Officer
Buy indirect
10,000
$3.90
$39.00K
Nijhawan Pardeep
4 Mar 2026
Chief Executive Officer
Buy indirect
10,000
$4.26
$42.56K
Nijhawan Pardeep
3 Mar 2026
Chief Executive Officer
Buy indirect
10,000
$3.63
$36.30K
Nijhawan Pardeep
2 Mar 2026
Chief Executive Officer
Buy indirect
1,000
$2.28
$2.28K
Nijhawan Pardeep
2 Mar 2026
Chief Executive Officer
Buy
2,000
$2.00
$4.00K
Nijhawan Pardeep
27 Feb 2026
Chief Executive Officer
Buy indirect
30,000
$2.22
$66.70K
Nijhawan Pardeep
26 Feb 2026
Chief Executive Officer
Buy
20,571
$1.58
$32.48K
Brooks Michael J
26 Feb 2026
President
Buy
2,000
$1.57
$3.14K

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 649,011
History held since 21 Dec 2016